Drug information for NASALIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SPRAY, METERED; NASAL
0.025MG/SPRAY
Discontinued
FLUNISOLIDE
flunisolide
IVAX RES
18148
2002-05-09 Letter
2002-05-09 Letter
1999-02-25 Review
Drug Adverse Effects information for NASALIDE
Role code
Indications
Reaction
# Reports
PS
MULTIPLE ALLERGIES
OSTEONECROSIS
2
C
ASTHMA
BONE PAIN
4
C
ASTHMA
CONJUNCTIVITIS
4
C
ASTHMA
EAR INFECTION
4
C
ASTHMA
GENERALISED OEDEMA
4
C
ASTHMA
JOINT SWELLING
4
C
ASTHMA
MYALGIA
4
C
ASTHMA
PAIN
4
C
ASTHMA
RESPIRATORY DISORDER
4
C
PRODUCT USED FOR UNKNOWN INDICATION
BONE PAIN
2
C
PRODUCT USED FOR UNKNOWN INDICATION
CONJUNCTIVITIS
2
C
PRODUCT USED FOR UNKNOWN INDICATION
EAR INFECTION
2
C
PRODUCT USED FOR UNKNOWN INDICATION
GENERALISED OEDEMA
2
C
PRODUCT USED FOR UNKNOWN INDICATION
JOINT SWELLING
2
C
PRODUCT USED FOR UNKNOWN INDICATION
MYALGIA
2
C
PRODUCT USED FOR UNKNOWN INDICATION
PAIN
2
C
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY DISORDER
2
Ads by Google